Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2001
10/04/2001EP1137460A2 Treatment of erectile dysfunction in diabetes patients
10/04/2001EP1137440A1 A stable product of isohexylnaphthazarins with penta- and tetra-cyclic triterpenes
10/04/2001EP1137439A2 Stabilization of macrolides
10/04/2001EP1137438A1 Formulation with an improved therapeutic range, containing nucleotide synthesis inhibitors
10/04/2001EP1137429A2 Bioflavonoids, anthocyanins and phenolic compounds from cherries for inhibiting inflammation
10/04/2001EP1137427A1 Cancer treatment composition and method using natural plant essential oils with signal transduction modulators
10/04/2001EP1137426A1 Cancer treatment composition and method using natural plant essential oils
10/04/2001EP1137425A1 Cancer treatment composition and method using signal transduction modulators and natural plant essential oils
10/04/2001EP1137424A1 Preparation which contains oligosaccharides and probiotics
10/04/2001EP1137420A1 Method for obtaining and using a combination of a purine and a nitrogen monoxide donor for preventing or treating sexual dysfunction
10/04/2001EP1137419A1 Uses of 1-amino-3-(n,n-dimethylamino)-propylidene-1,1-bisphosphonic acid
10/04/2001EP1137418A2 METHODS AND COMPOSITIONS FOR RESTORING CONFORMATIONAL STABILITY OF A PROTEIN OF THE p53 FAMILY
10/04/2001EP1137417A1 Use of selected modulators of p2 purinoceptors for the prevention of damage and mortality caused by global cerebral ischemia and ischemia-reperfusion
10/04/2001EP1137416A1 Use of long-chain n-alkyl derivatives of deoxynojirimycin for the manufacture of a medicament for the treatment of glycolipid storage diseases
10/04/2001EP1137415A1 Myt1 kinase inhibitors
10/04/2001EP1137414A1 Use of acetylcholinesterase inhibitors on the modulation of the hypothalamic-pituitary-gonadal axis
10/04/2001EP1137413A2 Non-peptide antagonists of glp-1 receptor and methods of use
10/04/2001EP1137411A1 Palladium-substituted bacteriochlorophyll derivatives and use thereof
10/04/2001EP1137410A1 Novel 4-dedimethy laminotetra cycline derivatives
10/04/2001EP1137409A2 Compositions and methods for amelioration of human female sexual dysfunction
10/04/2001EP1137408A1 Agent for lowering endothelin levels
10/04/2001EP1137407A1 The process for manufacturing formulation of topical beta blockers with improved efficacy
10/04/2001EP1137406A2 Transdermal patch for delivering volatile liquid drugs
10/04/2001EP1137405A1 Active ingredient matrix in the form of a biologically resorbable porous non-woven made of collagen fibrils, method for the production and use thereof
10/04/2001EP1137404A2 Nanoparticulate core-shell systems and use thereof in pharmaceutical and cosmetic preparations
10/04/2001EP1137402A1 Phospholipid compositions
10/04/2001EP1137399A2 Improvements in or relating to powders
10/04/2001EP1137398A1 Pharmaceutical preparation for inhalation of an opioid
10/04/2001EP1137393A2 Deodorant cosmetic composition
10/04/2001EP1137386A2 Use of hydroxydiphenyl ether as an antimalarial agent
10/04/2001EP1123094A4 Therapeutic compositions (ii)
10/04/2001EP1120408A9 Remedies for motor dysfunction and gapdh expression inhibitors
10/04/2001EP1079852B1 Composition based on pentoxifylline and anticytokin
10/04/2001EP0981350B1 Use of 9,10-secocholesta-5,7,10(19)-triene-1,3-diol, or alfacalcidol
10/04/2001EP0975631B1 5-aryl-3-(8-azabicyclo[3.2.1]oct-3-yl)-1,3,4-oxadiazol-2(3h)-one derivatives as 5-ht4 receptor ligands
10/04/2001EP0950408B1 Oily patches for external use containing diclofenac sodium
10/04/2001EP0892774A4 Pyronin antibacterials, process and novel intermediates thereto
10/04/2001EP0891326B1 Novel vitamin d analogues
10/04/2001EP0880528B1 Spiro-ketal derivatives and their use as therapeutic agents
10/04/2001EP0874841B1 1-benzenesulfonyl pyrrolidine derivatives as bradykinin receptor antagonists
10/04/2001EP0855999B1 1-(1,2-disubstituted piperidinyl)-4-substituted piperidine derivatives as tachykinin receptor antagonists
10/04/2001EP0853614B1 Substituted tetralylmethylen-oxindole analogues as tyrosine kinase inhibitors
10/04/2001EP0842174B1 Heterocyclic compounds for treating myocardial ischaemia
10/04/2001EP0841327B1 Triazole antifungal agent
10/04/2001EP0830350B1 n-(1-alkyl-5-phenyl-2,3,4,5-tetrahydro-1h-benzo[b][1,5]diazepin-3-yl)-acetamides
10/04/2001EP0828726B1 Tricyclic inhibitors of matrix metalloproteinases
10/04/2001EP0821685B1 Indole-3-carbonyl and indole-3-sulfonyl derivatives as platelet activating factor antagonists
10/04/2001EP0821665B1 Cyclobutane derivatives as inhibitors of squalene synthase and protein farnesyltransferase
10/04/2001EP0815123B1 Beta-sheet mimetics and use thereof as protease inhibitors
10/04/2001EP0815105B1 Heterocyclic substituted piperazinone derivatives as tachykinin receptor antagonists
10/04/2001EP0815081B1 Piperidinyl-2-alkyl substituted linear polyamines for the reduction of intracellular, endogenic polyamine levels such as putrescine, spermidine and spermine, and their impact on cell proliferation
10/04/2001EP0809635B1 Alpha-substituted hydrazides having calpain inhibitory activity
10/04/2001EP0802920B1 Antifungal fusacandins
10/04/2001EP0802909B1 Substituted oxazolidine calpain and/or cathepsin b inhibitors
10/04/2001EP0773222B1 Carbapenem derivative
10/04/2001EP0741712B1 Process for making hiv protease inhibitors
10/04/2001EP0730581B1 3-acylaminobenzazepines
10/04/2001EP0700399B1 36-derivatives of rifamycins and their use as antimicrobial agents
10/04/2001EP0688314B1 Prodrug derivatives of enzyme inhibitors with hydroxyl groups, methods of preparing them and their use
10/04/2001EP0687175B1 Method for treating emotional or mental illness and emotional or mental illness concomitant with seizures
10/04/2001EP0674646B1 Lipid derivatives of phosphonoacids for liposomal incorporation and method of use
10/04/2001EP0650482B1 Pesticidal pyrimidine compounds
10/04/2001EP0613465B1 1,3-substituted cycloalkenes and cycloalkanes as central nervous system agents
10/04/2001EP0552329B1 Methylen-oxindole derivatives and process for their preparation
10/04/2001EP0529002B1 Fluorescent porphyrin, and fluorescent phthalocyanine - polyethylene glycol, polyol, and saccharide derivatives as fluorescent probes
10/04/2001DE19947154A1 Substituierte 2-Thio-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use
10/04/2001DE10019067C1 Transdermal plaster comprising dofetilide, is useful for treatment of cardiovascular disorders
10/04/2001DE10014588A1 Sustained-release oral dosage form that floats in gastric fluid includes a blend of polyvinyl acetate and polyvinylpyrrolidone
10/04/2001DE10003767A1 Hautfreundliches Wirkstoffpflaster zur transdermalen Verabreichung nichtsteroidaler Antirheumatika Skin-friendly drug patch for transdermal administration of non-steroidal anti-inflammatory drugs
10/04/2001CA2659030A1 Methods for inhibiting angiogenesis and tumor growth
10/04/2001CA2429196A1 Characterization of grp94-ligand interactions and purification, screening, and therapeutic methods relating thereto
10/04/2001CA2408806A1 Quinolonecarboxylic acid derivative
10/04/2001CA2407036A1 A nucleic acid construct encoding a processing component derived from the n-terminal region of the hepatitis virus orf2, and an antigenic polypeptide
10/04/2001CA2405502A1 Method of treating hepatitis delta viral infection
10/04/2001CA2404964A1 Methods for detecting inflammation and inflammatory conditions
10/04/2001CA2404913A1 Sterol ester compositions
10/04/2001CA2404901A1 Composition and method for intervening neuronal death using sulfasalazine
10/04/2001CA2404780A1 Targeted chromosomal genomic alterations with modified single stranded oligonucleotides
10/04/2001CA2404756A1 Ligands directed to the non-secretory component, non-stalk region of pigr and methods of use thereof
10/04/2001CA2404712A1 Synergistic methods and compositions for treating cancer comprising antiproliferative cytotoxic and cytostatic agents
10/04/2001CA2404669A1 Condensed pyrazole derivatives, process for producing the same and use thereof
10/04/2001CA2404662A1 3-cyanoquinolines,3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
10/04/2001CA2404626A1 Novel piperazine derivatives
10/04/2001CA2404478A1 Glycosaminoglycans derived from the k5 polysaccharide having high anticoagulant and antithrombotic activity and process for their preparation
10/04/2001CA2404477A1 Tricyclic imidazopyridines
10/04/2001CA2404474A1 Prodrugs of imidazopyridine derivatives
10/04/2001CA2404466A1 Pyrano[2,3-c]imidazo[-1,2-a]pyridine derivatives for the treatment of gastrointestinal disorders
10/04/2001CA2404460A1 Alkylated imidazopyridine derivatives
10/04/2001CA2404448A1 Genes involved in intestinal inflammatory diseases and use thereof
10/04/2001CA2404445A1 Tricyclic protein kinase inhibitors
10/04/2001CA2404439A1 Diphenyl ether compounds useful in therapy
10/04/2001CA2404432A1 Compositions and methods for identifying and targeting cancer cells
10/04/2001CA2404428A1 High specificity marker detection
10/04/2001CA2404374A1 Use of metal salts to stabilize taxane-based compositions
10/04/2001CA2404370A1 Taxane-based compositions and methods of use
10/04/2001CA2404329A1 Treatment of cerebrovascular disease
10/04/2001CA2404172A1 Antiprogestins with partial agonist activity
10/04/2001CA2404157A1 Inhibition of a novel calcium injury current that forms in neurons during injury prevents neuronal cell death
10/04/2001CA2404147A1 Emulsion containing a plant extract, method for producing said emulsion and for obtaining a plant extract
10/04/2001CA2404060A1 Methods of treating neoplasia with combinations of target cell-specific adenovirus, chemotherapy and radiation
1 ... 6003 6004 6005 6006 6007 6008 6009 6010 6011 6012 6013 6014 6015 6016 6017 6018 6019 6020 6021 6022 6023 ... 7860